Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Tumor-Associated Macrophages Are Predictive of Survival in Relapsed and Refractory Hodgkin Lymphoma

Carla Casulo, MD, Maria Arcila, MD, Julie Teruya-Feldstein, MD, Jocelyn Maragulia, Craig H. Moskowitz, MD

Blood (2011) 118 (21): 2630.

https://doi.org/10.1182/blood.V118.21.2630.2630

Published: 2011

Journal Articles

Baseline Staging Evaluation in Lymphoma: The Role of FDG PET, CT, and Bone Marrow Biopsy

Andrew D Zelenetz, MD, PhD, Jocelyn Maragulia, Steven M. Horwitz, MD

Blood (2011) 118 (21): 2640.

https://doi.org/10.1182/blood.V118.21.2640.2640

Published: 2011

Journal Articles

Prospective Evaluation of Adequacy of Bone Marrow Biopsies Comparing Standard Jamshidi Needle to the OnControl Power Driver and Bone Marrow Biopsy System

Andrew D Zelenetz, MD, PhD, Jocelyn Maragulia, Allison Herrmann

Blood (2010) 116 (21): 4739.

https://doi.org/10.1182/blood.V116.21.4739.4739

Published: 2010

Journal Articles

Low Proliferation Index May Be Associated with Longer Time to First Therapy In Low Grade Follicular Lymphoma

Meirav Kedmi, MD, Cyrus V. Hedvat, MD, PhD, Jocelyn Maragulia, Andrew D Zelenetz, MD

Blood (2010) 116 (21): 4149.

https://doi.org/10.1182/blood.V116.21.4149.4149

Published: 2010

Journal Articles

Sequential Dose-Dense RCHOP Followed by ICE Consolidation (MSKCC protocol 01–142) without Radiotherapy for Patients with Primary Mediastinal Large B Cell Lymphoma

Craig Moskowitz, MD, Paul A Hamlin, Jr., Jocelyn Maragulia, Jessica Meikle, Andrew D Zelenetz, MD

Blood (2010) 116 (21): 420.

https://doi.org/10.1182/blood.V116.21.420.420

Published: 2010

Journal Articles

Sequential Chemotherapy Followed by High Dose Therapy and Autologous Stem Cell Rescue for Mantle Cell Lymphoma: Impact of MIB-1 on Outcome

Andrew D Zelenetz, MD, PhD, Craig Moskowitz, MD, Jocelyn Maragulia, Carol S. Portlock, Julie Teruya-Feldstein

Blood (2008) 112 (11): 3759.

https://doi.org/10.1182/blood.V112.11.3759.3759

Published: 2008

Journal Articles

Relapsed and Primary Refractory Diffuse Large B-Cell Lymphoma: Improving Outcome by Incorporating Involved Field Radiotherapy into a Comprehensive Second-Line High-Dose Therapy Strategy.

Bradford S. Hoppe, MD, Joachim Yahalom, MD, Tarun Kewalramani, MD, Paul A. Hamlin, MD, David Rice, RN, Daniel Filippa, MD, Jocelyn Maragulia, Alandra Weaver, Craig H. Moskowitz, MD

Blood (2007) 110 (11): 1893.

https://doi.org/10.1182/blood.V110.11.1893.1893

Published: 2007

NARROW

Tumor-Associated Macrophages Are Predictive of Survival in Relapsed and Refractory Hodgkin Lymphoma

Baseline Staging Evaluation in Lymphoma: The Role of FDG PET, CT, and Bone Marrow Biopsy

Prospective Evaluation of Adequacy of Bone Marrow Biopsies Comparing Standard Jamshidi Needle to the OnControl Power Driver and Bone Marrow Biopsy System

Low Proliferation Index May Be Associated with Longer Time to First Therapy In Low Grade Follicular Lymphoma

Sequential Dose-Dense RCHOP Followed by ICE Consolidation (MSKCC protocol 01–142) without Radiotherapy for Patients with Primary Mediastinal Large B Cell Lymphoma

Sequential Chemotherapy Followed by High Dose Therapy and Autologous Stem Cell Rescue for Mantle Cell Lymphoma: Impact of MIB-1 on Outcome

Relapsed and Primary Refractory Diffuse Large B-Cell Lymphoma: Improving Outcome by Incorporating Involved Field Radiotherapy into a Comprehensive Second-Line High-Dose Therapy Strategy.

Email alerts

ASH Publications

American Society of Hematology

Tumor-Associated Macrophages Are Predictive of Survival in Relapsed and Refractory Hodgkin Lymphoma

Baseline Staging Evaluation in Lymphoma: The Role of FDG PET, CT, and Bone Marrow Biopsy

Prospective Evaluation of Adequacy of Bone Marrow Biopsies Comparing Standard Jamshidi Needle to the OnControl Power Driver and Bone Marrow Biopsy System

Low Proliferation Index May Be Associated with Longer Time to First Therapy In Low Grade Follicular Lymphoma

Sequential Dose-Dense RCHOP Followed by ICE Consolidation (MSKCC protocol 01–142) without Radiotherapy for Patients with Primary Mediastinal Large B Cell Lymphoma

Sequential Chemotherapy Followed by High Dose Therapy and Autologous Stem Cell Rescue for Mantle Cell Lymphoma: Impact of MIB-1 on Outcome

Relapsed and Primary Refractory Diffuse Large B-Cell Lymphoma: Improving Outcome by Incorporating Involved Field Radiotherapy into a Comprehensive Second-Line High-Dose Therapy Strategy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only